glp-1 bulimia Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 and Eating Disorders: Risks

You should consult a healthcare provider if you are unsure about your current dose escalation step, experiencing persistent side effects, transitioning between different semaglutide products, combining semaglutide with other peptide stacks , or have underlying conditions that might affect how you metabolize the medication

These interactions deserve attention from both you and your healthcare provider

This hormone helps regulate blood sugar by increasing insulin production, slowing gastric emptying, and reducing appetite

Durvi Patel, MD , and Dr

Finally, the postprandial GLP-1 response is decreased in T2D

In the phase 2b trial, however, the reductions in glycated hemoglobin and body weight in participants treated with NNC0090-2746 were similar to those in the group treated with liraglutide (76), and no phase 3 trial of NNC0090-2746 has been reported yet